(HealthDay News) – A software monitoring program that tracks implantable cardioverter-defibrillator lead function could detect problems with the devices earlier than current monitoring processes.
MARLBOROUGH, Boston Scientific (NYSE: BSX) has received CE Mark approval for the new EMBLEM™ MRI Subcutaneous Implantable Defibrillator (S-ICD) System, as well as magnetic resonance (MR) conditional ...
SALT LAKE CITY, Utah--(BUSINESS WIRE)-- 3M Health Information Systems, an international leader in ICD-9 and ICD-10 coding and clinical terminology management, has released the 3M ICD-10 Code ...
Please provide your email address to receive an email when new articles are posted on . Abbott announced that the FDA approved its next-generation Bluetooth-capable implantable cardioverter ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved an extravascular ICD system to treat tachycardia that may cause sudden cardiac arrest. Placing ...
Innovative device offers first-line treatment for patients at risk of sudden cardiac arrest MARLBOROUGH, Mass., Boston Scientific Corporation has received FDA and CE Mark approval of the EMBLEM™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results